FDA Approves Keytruda / Pembrolizumab for HER2-Positive Gastric Cancer: A Potential New Hope for Patients Gastrointestinal 3 Mins Read Date: March 19, 2025On March 19, 2025, the U.S. Food and Drug Administration (FDA) granted traditional approval to pembrolizumab (Keytruda,…
FDA Approves TEVIMBRA for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma Gastrointestinal 3 Mins Read March 4, 2025 New Treatment Option for ESCC PatientsThe U.S. Food and Drug Administration (FDA) has approved TEVIMBRA® (tislelizumab-jsgr) in…
